proadifen has been researched along with EHS Tumor in 2 studies
Proadifen: An inhibitor of drug metabolism and CYTOCHROME P-450 ENZYME SYSTEM activity.
Excerpt | Relevance | Reference |
---|---|---|
"Phenobarbital pretreatment reduced both the antitumor efficacy and toxicity of CCNU (factor of approximately 0." | 1.27 | Effect of pretreatment with phenobarbital or SKF 525A on the toxicity and antitumor activity of lomustine. ( Siemann, DW, 1983) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wiebkin, P | 1 |
Sieg, MS | 1 |
Nelson, RE | 1 |
Hines, RN | 1 |
Prough, RA | 1 |
Siemann, DW | 1 |
2 other studies available for proadifen and EHS Tumor
Article | Year |
---|---|
Inhibition of metabolism-mediated cytotoxicity by 1,1-disubstituted hydrazines in mouse mastocytoma (line P815) cells.
Topics: Animals; Biotransformation; Cell Survival; Cells, Cultured; Coumarins; Cyclophosphamide; Hydrazines; | 1982 |
Effect of pretreatment with phenobarbital or SKF 525A on the toxicity and antitumor activity of lomustine.
Topics: Animals; Female; Lomustine; Mice; Mice, Inbred C3H; Nitrosourea Compounds; Phenobarbital; Proadifen; | 1983 |